US Patent 11958893 Methods for modulating an immune response
Patent 11958893 was granted and assigned to Cue Biopharma on April, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 17 Apr, 2024
Golden AI
Edits made to:
Infobox (+42 properties)
Article (+489 characters)
US Patent 11958893 Methods for modulating an immune response
Article
Patent abstract
The present disclosure provides methods of modulating an immune response in an individual. The present disclosure provides methods of treatment. The present disclosure provides methods comprising administering a multimeric polypeptide (synTac) and an immune checkpoint inhibitor to an individual. The present disclosure provides methods comprising administering a multimeric polypeptide (synTac) to an individual who is undergoing treatment with immune checkpoint inhibitor.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Rodolfo J. Chaparro0
Ronald D. Seidel, III0
Date of Patent
April 16, 2024
0Patent Application Number
173818580
Date Filed
July 21, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11958893 Methods for modulating an immune response
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
